semaglutide news november 28 2025 The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing A Review of the Oral

Nausea Vomiting Diarrhea In addition to gastrointestinal issues, Semaglutide may also contribute to muscle loss, particularly during rapid weight loss

The device is user-friendly and designed for easy injection

Clinical Effectiveness Clinical studies have shown that semaglutide significantly reduces body weight and improves glycemic control when used consistently, along with diet and exercise

Also, check your blood for low blood sugar

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 10, 513519

And in the liver specifically, it drives fat oxidation at rates that produce the MASLD improvements seen in trials